CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2016		Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 30,451		$ 42,229
Available for sale securities	903		753
Trade accounts and grants receivable, net	1,604		1,078
Landlord receivable	115		567
Prepaid expenses and other current assets	2,079		2,610
Total current assets	35,152		47,237
Property, plant and equipment, net and construction in progress	4,726		7,539
Deferred license fees	145		322
Deposits and other long-term assets	1,011		1,299
Equity method investment in Asterias, at fair value (Note 4)	92,210		0
Equity method investment in Ascendance	3,482		4,671
Intangible assets, net	10,848	[1]	33,592
TOTAL ASSETS	147,574		94,660
CURRENT LIABILITIES
Accounts payable and accrued liabilities	7,176	[1]	9,377
Capital lease liability, current portion	173		38
Promissory notes, current portion	95		95
Related party convertible debt, net of discount, current portion	357		0
Deferred grant income	0		2,513
Deferred license and subscription revenue, current portion	537		439
Total current liabilities	8,338		12,462
LONG-TERM LIABILITIES
Deferred revenues, net of current portion	385		615
Deferred rent liabilities, net of current portion	46		158
Lease liability	1,348		4,400
Related party convertible debt, net of discount, net of current portion	954		324
Promissory notes, net of current portion	173		220
Capital lease, net of current and other liabilities	89		34
TOTAL LIABILITIES	11,333		18,213
Commitments and contingencies (Note 13)
SHAREHOLDERS' EQUITY
Preferred shares, no par value, 2,000 shares authorized; none issued and outstanding	0		0
Common shares, no par value, 150,000 shares authorized; 103,392 shares issued and 102,772 shares outstanding at September 30, 2016; 94,894 issued and 90,421 outstanding at December 31, 2015	313,506		274,342
Accumulated other comprehensive loss	(690)		(237)
Accumulated deficit	(190,534)		(229,181)
Treasury stock at cost: 620 shares at September 30, 2016 and 4,473 shares at December 31, 2015	(2,891)		(18,033)
BioTime, Inc. shareholders' equity	119,391		26,891
Non-controlling interest	16,850		49,556
Total shareholders' equity	136,241		76,447
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 147,574		$ 94,660

[1] Reflects the effect of the Deconsolidation.